InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,858.27
(
0.74%
)
US TECH 100
19,883.20
(
0.75%
)
Dow Jones
43,045.97
(
0.42%
)
Brent Oil
77.48
(
0.01%
)
Bitcoin
65,748.34
(
4.60%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jadite

Send PM Follow Ignore
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

jadite

Re: None

Monday, 07/23/2012 2:38:14 PM

Monday, July 23, 2012 2:38:14 PM

Post# of 26138
I wonder if Bio-T-Gels failure to launch (TEVA) could be due to logistics. This site tracks drug shortages and shows Paddock and Watson with no T cypionate injections and Paddock attributing the shortage to lack of raw material.

Remember the gel filling machine and the manufacturing and QA positions? Other web sites show both a shortage and unreliable vendors. Could BPAX be planning to provide their own raw material?

http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=638
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up